Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Biotechnol Adv ; 33(2): 277-87, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25698504

RESUMEN

The increasing incidence of diseases affecting the central nervous system (CNS) demands the urgent development of efficient drugs. While many of these medicines are already available, the Blood Brain Barrier and to a lesser extent, the Blood Spinal Cord Barrier pose physical and biological limitations to their diffusion to reach target tissues. Therefore, efforts are needed not only to address drug development but specially to design suitable vehicles for delivery into the CNS through systemic administration. In the context of the functional and structural versatility of proteins, recent advances in their biological fabrication and a better comprehension of the physiology of the CNS offer a plethora of opportunities for the construction and tailoring of plain nanoconjugates and of more complex nanosized vehicles able to cross these barriers. We revise here how the engineering of functional proteins offers drug delivery tools for specific CNS diseases and more transversally, how proteins can be engineered into smart nanoparticles or 'artificial viruses' to afford therapeutic requirements through alternative administration routes.


Asunto(s)
Enfermedades del Sistema Nervioso Central/tratamiento farmacológico , Sistema Nervioso Central/efectos de los fármacos , Sistemas de Liberación de Medicamentos , Técnicas de Transferencia de Gen , Barrera Hematoencefálica/efectos de los fármacos , Sistema Nervioso Central/patología , Enfermedades del Sistema Nervioso Central/patología , Humanos , Nanomedicina , Nanopartículas/química , Nanopartículas/uso terapéutico , Ácidos Nucleicos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA